CIPHER PHARMACEUTICALS INC's ticker is CPHRF and the CUSIP is 17253X105. A total of 20 filers reported holding CIPHER PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,338,000 | +10.0% | 447,800 | 0.0% | 2.38% | -4.3% |
| Q1 2016 | $2,125,000 | +1.4% | 447,800 | 0.0% | 2.48% | -2.5% |
| Q4 2015 | $2,096,000 | +26.3% | 447,800 | 0.0% | 2.55% | +46.2% |
| Q3 2015 | $1,659,000 | -56.7% | 447,800 | 0.0% | 1.74% | -53.2% |
| Q2 2015 | $3,833,000 | -5.5% | 447,800 | 0.0% | 3.72% | -12.6% |
| Q1 2015 | $4,057,000 | -48.0% | 447,800 | -17.1% | 4.26% | -42.5% |
| Q4 2014 | $7,801,000 | – | 540,300 | – | 7.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Raffles Associates | 447,800 | $2,338,000 | 2.38% |
| Grandeur Peak Global Advisors, LLC | 4,415,500 | $22,082,000 | 2.29% |
| TAYLOR ASSET MANAGEMENT INC | 996,800 | $5,209,000 | 1.49% |
| MONTRUSCO BOLTON INVESTMENTS INC. | 2,272,032 | $11,809,000 | 0.75% |
| AWM Investment Company, Inc. | 211,300 | $1,103,000 | 0.24% |
| INTACT INVESTMENT MANAGEMENT INC. | 375,500 | $2,441,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 681,384 | $3,542,000 | 0.02% |
| Connor, Clark & Lunn Investment Management Ltd. | 52,000 | $270,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,110 | $6,000 | 0.00% |
| LPL Financial LLC | 11,000 | $60,000 | 0.00% |